Onyx Equities is set to begin renovations at the 2 million-square-foot former Merck & Co. campus in Kenilworth, having teamed with a known life sciences developer to spearhead its plan to upgrade and bring new tenants to the property.
Life sciences companies remain a leading driver of commercial real estate in New Jersey, accounting for more than a third of all office leases during the first half of 2023 and fueling a pipeline of deals for lab and manufacturing space.
Onyx Equities has revealed new details of its plan for the 2 million-square-foot former Merck & Co. campus in Kenilworth, as it prepares a broad campaign to attract life sciences and biotechnology firms seeking both turnkey space and new ground-up facilities.
